JPRN-UMIN000004326
Completed
未知
Quantification of amyloid deposition using positron emission tomography with [C-11]AZD2184 - Amyloid imaging with [C-11]AZD2184
ational Institute of Radiological Sciences0 sites40 target enrollmentOctober 8, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Institute of Radiological Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria for patients \- Other psychiatric disorders including drug dependence \- Brain organic diseases including cerebrovascular diseases, Parkinson's disease and other related disorders \- Serious medical illness \- Subjects who are judged as not suitable for participation in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Amyloid imaging study using positron emission tomography with [F-18]FACT for dementiaDementiaJPRN-UMIN000001420ational Institute of Radiological Sciences60
Not yet recruiting
Phase 4
Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and of glucose metabolism with 18F-FDG PET in individuals enrolled in the ALFA project2024-519961-23-00Barcelonabeta Brain Research Center400
Completed
Not Applicable
Measurement of amyloid deposit in the brain of idiopathic normal-pressure hydrocephalusJPRN-UMIN000003764Cyclotron and Radioisotope Center (CYRIC), Tohoku University90
Recruiting
Phase 1
Amyloid Brain PET studyDementiaD003704JPRN-jRCTs032230491Takahashi Miwako20
Suspended
Phase 1
Positron Emission Tomography of Amyloid in Alzheimer's DiseaseAlzheimer's DiseaseNCT00205621Amsterdam UMC, location VUmc50